VRAX - viraxbiolabs.com Enterprise Value

Brandmark of Virax Biolabs Corp (VRAX)

Virax Biolabs Group (VRAX) business relies on the operation of diagnostic hubs in Asia and Britain, producing infection detection systems. The digital immunoassay environment, coupled with the ViraxClear AI service, retains B2B partners through unique data. However, niche oversaturation has led to price dumping and the liquidation of remaining inventory. This chart of the enterprise value is currently fixed at -4.50.

Virax Biolabs Group Ltd (VRAX) - Total Company Value from 11/23/2025 to 10/30/2026

Virax Biolabs Group (VRAX) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart Virax Biolabs Group Limited|VRAX - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Virax Biolabs|VRAX - Real Price to Acquire Entire Company
- book value of equity indicators:
Equity per Share Virax Biolabs|VRAX - Company Book Value|Market Cap to Net Assets Ratio viraxbiolabs.com|VRAX - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Virax Biolabs Group|VRAX - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio viraxbiolabs.com|VRAX - Company Aggregate Debts|Debts to Book Capitalization Virax Biolabs|VRAX - Company Long-Term Debt|Company Short-Term Indebtedness Virax Biolabs|Quick Ratio viraxbiolabs.com
- earnings and valuation multiples indicators:
VRAX - Company Net Income
Summary company analytics:VRAX (Virax Biolabs Group Limited)
Manufactured product of Virax Biolabs Group Limited

Demand for viral infection diagnostics and government contracts for Virax Biolabs Group (VRAX) directly determine the market attractiveness of its assets. The EV history reflects the total enterprise value by summing market capitalization and debt minus liquidity, allowing investors to assess the actual cost of acquiring the company and avoid overpaying for an inflated asset.

Competitors of Virax Biolabs Group (VRAX)

Value Adjusted for Debt and Cash A|Quest - Enterprise Value|ILMN - Enterprise Value|EXAS (Exact Sciences) - Real Price to Acquire Entire Company|Business Value RVTY|Total Company Value Bio-Rad|Real Price to Acquire Entire Company Anbio Biotechnology Ltd (NNNN)|Enterprise Value SHC|QDEL - Total Enterprise Value|Enterprise Value OPK (OPKO Health, Inc.)|CDNA: Business Value|Maravai LifeSciences Holdings, Inc. - Enterprise Value|FLGT - Enterprise Value|Fluidigm (LAB) - Total Company Value|Business Value CTKB|OSUR (OraSure Technologies) - Enterprise Value|Enterprise Value Exagen Diagnostics|Total Company Value MDxHealth (MDXH)|Total Company Value LUCD (Lucid Diagnostics, Inc.)|Prenetics - Real Price to Acquire Entire Company|Insight Molecular Diagnostics, Inc. (IMDX) - Total Enterprise Value|TRIB - Total Company Value|Company Buyout Price prophaselabs.com PRPH|AIMD: Enterprise Value|CODX - Company Buyout Price|Total Company Value Heart Test Laboratories Inc.|Biomerica Inc (BMRA) - Company Buyout Price|Real Price to Acquire Entire Company CDIO (Cardio Diagnostics)|Total Company Value BJDX (bluejaydx.com)|Enterprise Value AWH (Aspira Women's Health Inc.)|Company Buyout Price Accelerate Diagnostics Inc. (AXDX)|CNTG - Total Company Value|Value Adjusted for Debt and Cash ENZ (Enzo Biochem, Inc.)|FRES: Enterprise Value|Genetic Technologies Limited (GENE) - Enterprise Value|Real Price to Acquire Entire Company ME|Business Value PMD (Psychemedics Corp.)